Diabetes control. CALM-D will include measurement of HbA1c, fasting glucose, and response to oral glucose challenge at Baseline (run-in/assessment session 2), and at both 6- and 12-month follow-up. Patients will be excluded at Baseline if HbA1c > 11%.